Skip to main content

Table 2 Antibiotic, Bronchodilator and Steroid use Prior to and Following CEM Introduction

From: Effect of point of care information on inpatient management of bronchiolitis

 

Pre-CEM 2000 – 2001 n = 142

Post-CEM 2001 – 2002 n = 174

Difference (95% CI)

p-value

Antibiotic Prescription Patterns for Bronchiolitis Patients

Antibiotics, n (%)

49 (34.5)

38 (21.8)

12.7 (2.7, 22.5)

0.020

# antibiotics received:

    

   0, n (%)

93 (65.5)

136 (78.2)

  

   1, n (%)

28 (19.7)

22 (12.6)

  

   2, n (%)

16 (11.3)

12 (6.9)

  

   3, n (%)

4 (2.8)

3 (1.7)

  

   4, n (%)

1 (0.7)

1 (0.6)

  

Median (range)

0 (0, 4)

0 (0, 4)

0 (0,0)

0.019

Bronchodilator Prescription Patterns for Bronchiolitis Patients

Bronchodilators, n(%)

134 (94.4)

163 (93.7)

0.7 (-5.1, 6.1)

0.873

Salbutamol received, n (%)

102 (71.8)

77 (44.3)

27.6 (16.9, 37.4)

<0.001

Epinephrine received, n (%)

72 (50.7)

120 (69.0)

-18.3 (-28.6, -7.4)

0.005

Number of different bronchodilators received

    

   0 received, n (%)

8 (5.6)

11 (6.3)

  

   1 received, n (%)

57 (40.1)

64 (36.8)

  

   2 received, n (%)

37 (26,1)

37 (21.3)

  

   3 received, n (%)

18 (12.7)

34 (19.5)

  

   ≥ 4 received, n (%)

22 (15.5)

28 (16.1)

  

Median (range)

2 (0, 8)

2 (0, 9)

0 (0, 0)

0.637

Steroid Prescription Patterns for Bronchiolitis Patients

Inhaled Steroids

    

   0, n (%)

132 (93.0)

167 (96.0)

  

   1, n (%)

10 (7.0)

6 (3.4)

  

   2, n (%)

0 (0.0)

1 (0.6)

  

   Median (range)

0 (0, 1)

0 (0, 2)

0 (0, 0)

0.510

Systemic Steroids

    

   0, n (%)

129 (90.8)

157 (90.2)

  

   1, n (%)

13 (9.2)

17 (9.8)

  

   Median (range)

0 (0, 1)

0 (0,1)

0 (0, 0)

0.629

Total Inhaled and Systemic steroids

    

   0, n (%)

122 (85.9)

152 (87.4)

  

   1, n (%)

17 (12.0)

19 (10.9)

  

   2, n (%)

3 (2.1)

3 (1.7)

  

   Median (range)

0 (0, 2)

0 (0,2)

0 (0, 0)

0.983